Influenza and other respiratory virusesHumansRespiratory Syncytial Virus InfectionsUnited StatesMiddle AgedFemale
Prevalence and Age at Diagnosis of Risk Factors for Severe Respiratory Syncytial Virus Disease Among US Adults: An Analysis of 2011-2020 NHANES Data.
Emily K Horn, David Singer, Alison Booth, Hai Nguyen, Cynthia Saiontz-Martinez, Ariel Berger
Published: 202510.1111/irv.70181
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) vaccines are approved in the United States (US) among adults ≥ 60 years of age (YoA). Understanding disparities in risk factors (RFs) for severe RSV disease by social determinants of health is crucial for…
Preview only. Read the full abstract at the source